✦ LIBER ✦

Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy

✍ Scribed by You, J H S; Tsui, K K N; Wong, R S M; Cheng, G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ability of VKORC1 and CYP2C9 to predict

✍ N. S. FERDER; C. S. EBY; E. DEYCH; J. K. HARRIS; P. M. RIDKER; P. E. MILLIGAN; S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Contribution of VKORC1 and CYP2C9 polymo

✍ Gin Gin Gan; Maude E. Phipps; Michael M. T. Lee; Liang S. Lu; Rajallectchumy Y. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 140 KB

Contribution of age, body weight, and CY

✍ Liyan Miao; Jian Yang; Chenrong Huang; Zhenya Shen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 166 KB

Combination of Phenotype Assessments and

✍ Michaud, V; Vanier, M-C; Brouillette, D; Roy, D; Verret, L; Noel, N; Taillon, I; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

A PK–PD Model for Predicting the Impact

✍ Hamberg, A-K; Dahl, M-L; Barban, M; Scordo, M G; Wadelius, M; Pengo, V; Padrini, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Influence of CYP2C9 and VKORC1 1173C/T G

✍ Limdi, NA; McGwin, G; Goldstein, JA; Beasley, TM; Arnett, DK; Adler, BK; Baird, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB